GlassScriptPhysician profile
Robert A Iaffaldano
NPI 1043274145
$4,805.92
in general payments reported to CMS, 2019-2025
32 companies · $492 in 2025
The $492 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $344 · 2021: $821 · 2022: $683 · 2023: $772 · 2024: $1,045 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,308.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $941.98 | 2019-2025 | |
| Pfizer INC. | $629.90 | 2019-2025 | |
| Medtronic, INC. | $513.11 | 2021-2024 | Cobalt Dr Mri Surescan, Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $498.27 | 2019-2023 | Xarelto |
| Abbott Laboratories | $434.24 | 2021-2024 | Perclose Prostyle, Xact |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $199.50 | 2019-2024 | Lifevest |
| Amgen INC. | $173.79 | 2019-2025 | Repatha, Repatha |
| Jenavalve Technology, INC. | $162.44 | 2022 | |
| Novo Nordisk INC | $119.37 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Limflow INC. | $116.55 | 2023 | Limflow System |
| Medtronic Vascular, INC. | $116.45 | 2020 | |
| Boston Scientific Corporation | $101.71 | 2019-2023 | Bodyguardian |
| Angiodynamics, INC. | $100.87 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $100.38 | 2021-2025 | Eliquis |
| Cagent Vascular INC | $82.25 | 2025 | Serrantor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $61.29 | 2023-2025 | Cios Alpha |
| Scpharmaceuticals INC. | $54.22 | 2023-2024 | |
| Amarin Pharma, INC. | $44.69 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.62 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $40.52 | 2019 | |
| Lundbeck LLC | $39.72 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $35.77 | 2019 | |
| Inspire Medical Systems, INC. | $31.44 | 2023 | Inspire |
| Merck Sharp & Dohme LLC | $31.13 | 2021-2025 | Verquvo |
| Lexicon Pharmaceuticals, INC. | $20.65 | 2024 | |
| Edwards Lifesciences Corporation | $19.23 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $19.11 | 2021 | |
| Atricure, INC. | $16.65 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Portola Pharmaceuticals, LLC | $15.75 | 2019 | |
| Alnylam Pharmaceuticals INC. | $14.64 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.97 | 2022 | |
| Chiesi USA, INC. | $12.71 | 2023 | Kengreal, Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Iaffaldano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.